<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03487107</url>
  </required_header>
  <id_info>
    <org_study_id>PCD-DDAG181PA-16-007</org_study_id>
    <nct_id>NCT03487107</nct_id>
  </id_info>
  <brief_title>Phase 3 Study of Yimitasvir Phosphate Capsules</brief_title>
  <official_title>A Multicenter, Single-arm, Open-label Study to Investigate the Efficacy and Safety of Yimitasvir Phosphate (DAG181)/Sofosbuvir(SOF) Combination for 12 Weeks in Subjects With Chronic Genotype 1 HCV Infection</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sunshine Lake Pharma Co., Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sunshine Lake Pharma Co., Ltd.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The safety, tolerability and antiviral activity of DAG181/SOF in treatment-naive and
      treatment-experienced patients with chronic hepatitis C virus (HCV) genotype 1 infection.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A phase III, multicenter, single-arm, open-label study to assess the safety, tolerability and
      antiviral activity of DAG181/SOF combination for 12 weeks in adult subjects with chronic
      genotype 1 HCV infection.

      Approximately 360 HCV genotype 1 subjects without cirrhosis will be enrolled,
      treatment-experienced subjects are ≤20%. All subjects will receive DAG181 100 mg/ SOF 400 mg
      once daily for 12 weeks，with subsequent observation for 24 weeks after cessation of
      treatment.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">April 3, 2018</start_date>
  <completion_date type="Anticipated">June 24, 2019</completion_date>
  <primary_completion_date type="Anticipated">April 1, 2019</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of subjects with sustained virologic response 12 weeks after discontinuation of therapy(SVR12)</measure>
    <time_frame>Posttreatment Week 12</time_frame>
    <description>SVR12 was defined as HCV RNA &lt; the lower limit of quantitation (LLOQ) at 12 weeks after discontinuation of therapy</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Safety and tolerability were evaluated based on adverse events</measure>
    <time_frame>Up to posttreatment week 24</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percentage of subjects with sustained virologic response 4 and 24 weeks after discontinuation of therapy (SVR4 and SVR24)</measure>
    <time_frame>Posttreatment Weeks 4 and 24</time_frame>
    <description>SVR4 and SVR24 were defined as HCV RNA &lt; the lower limit of quantitation (LLOQ) at 4 and 24 weeks after discontinuation of therapy, respectively.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>HCV RNA change from baseline</measure>
    <time_frame>Up to posttreatment week 24</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of subjects with virologic failure</measure>
    <time_frame>Up to posttreatment week 24</time_frame>
    <description>On-treatment virologic failure:
confirmed HCV RNA ≥ the lower limit of quantitation (LLOQ) after having previously had HCV RNA &lt;the lower limit of quantitation (LLOQ) while on treatment;
confirmed ≥ 1 log10 IU/mL increase in HCV RNA from nadir while on treatment;
HCV RNA persistently ≥the lower limit of quantitation (LLOQ) through 8 weeks of treatment.
Virologic relapse:
Confirmed HCV RNA ≥the lower limit of quantitation (LLOQ) during the posttreatment period having achieved HCV RNA &lt;the lower limit of quantitation (LLOQ) at last on-treatment visit.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of subjects with viral resistance to DAG181 and/or SOF</measure>
    <time_frame>Up to posttreatment week 24</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">360</enrollment>
  <condition>Chronic HCV Infection</condition>
  <arm_group>
    <arm_group_label>SOF 400 mg+DAG181 100 mg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients with genotype 1 HCV infection without cirrhosis will receive SOF 400 mg+DAG181 100 mg for 12 weeks.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>SOF</intervention_name>
    <description>400 mg tablet administered orally once daily</description>
    <arm_group_label>SOF 400 mg+DAG181 100 mg</arm_group_label>
    <other_name>sofosbuvir</other_name>
    <other_name>Sovaldi®</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>DAG181</intervention_name>
    <description>100 mg capsule administered orally once daily</description>
    <arm_group_label>SOF 400 mg+DAG181 100 mg</arm_group_label>
    <other_name>Yimitasvir</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Willing and able to provide written informed consent;

          2. Male or female, age≥18 years;

          3. A female subject is eligible to enter the study if it is confirmed that she is:

               1. Of non-childbearing potential (i.e., women who have had a hysterectomy, have both
                  ovaries removed or medically documented ovarian failure, or are
                  postmenopausal-women &gt; 50 years of age with cessation (for≥12 months) of
                  previously occurring menses), or

               2. Of childbearing potential (Women≤50 years of age with amenorrhea will be
                  considered to be of childbearing potential). These women must have a negative
                  serum pregnancy test at screening and negative urine pregnancy test at baseline
                  before first dose of study drugs, and must use specific contraceptive methods
                  from screening until 90 days after last dose of study drugs, such as complete
                  abstinence from intercourse, vaginal ring, cervical cap or contraceptive
                  diaphragm, IUD, etc.

          4. All male subjects must agree to consistently and correctly use specific contraceptive
             methods with their female partner from screening until 90 days after last dose of
             study drugs(except for surgical sterilization), such as complete abstinence from
             intercourse, condom, and their female partner use contraceptives , vaginal ring ,
             cervical cap or contraceptive diaphragm, IUD, etc;

          5. Male subjects must agree to refrain from sperm donation from the date of screening
             until 90 days after the last dose of study drugs;

          6. Confirmation of chronic HCV infection documented by either:

               1. A positive anti-HCV antibody test or positive HCV RNA or positive HCV genotyping
                  test at least 6 months prior to the Baseline/Day 1 visit, or

               2. A liver biopsy performed prior to the Baseline/Day 1 visit with evidence of
                  chronic HCV infection.

          7. Serological detection of anti-HCV antibodies was positive at screening;

          8. HCV RNA≥1×104 IU/mL at Screening;

          9. HCV genotype 1a, 1b, or mixed 1a/1b at screening as determined by the Central
             Laboratory;

         10. Classification as treatment naive or treatment experienced;

         11. Absence of cirrhosis.

        Exclusion Criteria:

          1. Investigator assessed subjects have other clinically significant abnormalities (other
             than HCV), such as uncontrollable heart disease, respiratory, gastrointestinal, blood,
             nervous or other medical disorders, which may interfere with treatment, assessment, or
             compliance with the protocol;

          2. Laboratory results outside of acceptable ranges at Screening;

          3. HBsAg serology test results were positive at Screening;

          4. HIV antibody test results were positive at Screening;

          5. Prior exposure to approved or experimental HCV-specific direct-acting antiviral agent;

          6. Pregnant female or male with pregnant female partner.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lai Wei, Doctor</last_name>
    <role>Study Chair</role>
    <affiliation>Peking University People's Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Lai Wei, Doctor</last_name>
    <phone>010-66583776</phone>
    <email>weelai@163.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Beijing Ditan Hospital Affiliated to Capital Medical University</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100020</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Wen Xie</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Peking University First Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100034</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Guiqiang Wang</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Peking University People's Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100044</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Lai Wei, Doctor</last_name>
      <phone>010-66583776</phone>
      <email>weelai@163.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Beijing Friendship Hospital，Capital Medical University</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100050</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jidong Jia</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Beijing YouAn Hospital,Capital Medical University</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100069</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The First Affiliated Hospital of Fujian Medical University</name>
      <address>
        <city>Fuzhou</city>
        <state>Fujian</state>
        <zip>350005</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Yueyong Zhu</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Mengchao Hepatobiliary Hospital of Fujian Medical University</name>
      <address>
        <city>Fuzhou</city>
        <state>Fujian</state>
        <zip>350025</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Minghua Lin</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>The First Hospital of Lanzhou University</name>
      <address>
        <city>Lanzhou</city>
        <state>Gansu</state>
        <zip>730000</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Guangzhou Eighth People's Hospital</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510060</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nanfang Hospital of Southern Medical University</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510515</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jinlin Hou</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hainan General Hospital</name>
      <address>
        <city>Haikou</city>
        <state>Hainan</state>
        <zip>570311</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Feng Lin</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Third Hospital of Hebei Medical University</name>
      <address>
        <city>Shijiazhuang</city>
        <state>Hebei</state>
        <zip>050051</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Caiyan Zhao</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>The First Affiliated Hospital of Xinxiang Medical University</name>
      <address>
        <city>Xinxiang</city>
        <state>Henan</state>
        <zip>453100</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Daokun Yang</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>People's Hospital of Zhengzhou</name>
      <address>
        <city>Zhengzhou</city>
        <state>Henan</state>
        <zip>450003</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Yingjie Ma</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Henan Provincial Infectious Disease Hospital</name>
      <address>
        <city>Zhengzhou</city>
        <state>Henan</state>
        <zip>450061</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Guangming Li</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Central Hospital of Wuhan</name>
      <address>
        <city>Wuhan</city>
        <state>Hubei</state>
        <zip>430010</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jie Wu</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Union Hospital Affiliated with Tongji Medical College of Huazhong University of Science and Technology</name>
      <address>
        <city>Wuhan</city>
        <state>Hubei</state>
        <zip>430022</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tongji Hospital Affiliated to Tongji Medical College of Huazhong University Science &amp; Technology</name>
      <address>
        <city>Wuhan</city>
        <state>Hubei</state>
        <zip>430030</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Qin Ning</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Renmin Hospital of Wuhan University</name>
      <address>
        <city>Wuhan</city>
        <state>Hubei</state>
        <zip>430060</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hunan Provincial People's Hospital</name>
      <address>
        <city>Changsha</city>
        <state>Hunan</state>
        <zip>410000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Xiaoxuan Hu</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Xiangya Hospital, Central South University</name>
      <address>
        <city>Changsha</city>
        <state>Hunan</state>
        <zip>410008</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jun Quan</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>The People's Liberation Army No.81 Hospital</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <zip>210002</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Maorong Wang</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Second Hospital of Nanjing</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <zip>210003</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Yongfeng Yang</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Fifth People's Hospital of Wuxi</name>
      <address>
        <city>Wuxi</city>
        <state>Jiangsu</state>
        <zip>214073</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Tong Sun</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Affiliated Hospital of Xuzhou Medical Hospital</name>
      <address>
        <city>Xuzhou</city>
        <state>Jiangsu</state>
        <zip>221002</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Xuebing Yan</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Third People's Hospital of Zhenjiang</name>
      <address>
        <city>Zhenjiang</city>
        <state>Jiangsu</state>
        <zip>212004</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Youwen Tan, Doctor</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>The First Affiliated Hospital of NanChang University</name>
      <address>
        <city>Nanchang</city>
        <state>Jiangxi</state>
        <zip>330006</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The First Hospital of Jilin University</name>
      <address>
        <city>Chang Chun</city>
        <state>Jilin</state>
        <zip>130021</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jinglan Jin</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Sixth People's Hospital of Shenyang</name>
      <address>
        <city>Shenyang</city>
        <state>Liaoning</state>
        <zip>110006</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ping An</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200020</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Qing Xie, Doctor</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Shanghai Public Health Clinical Center</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>201500</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jiefei Wang</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Tangdu Hospital</name>
      <address>
        <city>Xi'an</city>
        <state>Shanxi</state>
        <zip>710038</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Zhansheng Jia</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>The First Affiliated Hospital of Xi'an Jiaotong University</name>
      <address>
        <city>Xi'an</city>
        <state>Shanxi</state>
        <zip>710061</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Yingren Zhao</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>West China Hospital, Sichuan University</name>
      <address>
        <city>Chengdu</city>
        <state>Sichuan</state>
        <zip>610041</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Lang Bai</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sichuan Provincial People's Hospital</name>
      <address>
        <city>Chengdu</city>
        <state>Sichuan</state>
        <zip>610072</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Xingxiang Yang</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>The First Affiliated Hospital of Wenzhou Medical University</name>
      <address>
        <city>Wenzhou</city>
        <state>Zhejiang</state>
        <zip>325000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Yongping Chen</last_name>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 26, 2018</study_first_submitted>
  <study_first_submitted_qc>April 1, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">April 3, 2018</study_first_posted>
  <last_update_submitted>April 1, 2018</last_update_submitted>
  <last_update_submitted_qc>April 1, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 3, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Chronic Genotype 1 HCV Infection</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sofosbuvir</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

